# Compass Therapeutics, Inc.: Form 8-K/A, filed Aug 5, 2021

- Company: [Compass Therapeutics, Inc.](/companies/cmpx.md) (CIK 1738021)
- Form: 8-K/A
- Filed: 2021-08-05
- Accepted by EDGAR: Aug 4, 2021, 19:20 ET
- Period: 2021-06-25
- Accession: 0000950170-21-000831
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1738021/000095017021000831/cmpx-20210625.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1738021/000095017021000831/

## Items reported

- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1738021/000095017021000831/cmpx-20210625.htm

Filed Aug 5, 2021.
Source: SEC EDGAR, the filing index for accession 0000950170-21-000831. Last ingested by Listed: Nov 10, 2026, 16:45 ET. No prices; not investment advice.
